ATE109659T1 - Arzneimittelzusammensetzungen. - Google Patents

Arzneimittelzusammensetzungen.

Info

Publication number
ATE109659T1
ATE109659T1 AT87902224T AT87902224T ATE109659T1 AT E109659 T1 ATE109659 T1 AT E109659T1 AT 87902224 T AT87902224 T AT 87902224T AT 87902224 T AT87902224 T AT 87902224T AT E109659 T1 ATE109659 T1 AT E109659T1
Authority
AT
Austria
Prior art keywords
coating materials
agents
composition
pharmaceutical agent
medicinal compositions
Prior art date
Application number
AT87902224T
Other languages
English (en)
Inventor
Young W Cho
Original Assignee
Eurasiam Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurasiam Lab filed Critical Eurasiam Lab
Application granted granted Critical
Publication of ATE109659T1 publication Critical patent/ATE109659T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
AT87902224T 1986-03-21 1987-03-12 Arzneimittelzusammensetzungen. ATE109659T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84262586A 1986-03-21 1986-03-21

Publications (1)

Publication Number Publication Date
ATE109659T1 true ATE109659T1 (de) 1994-08-15

Family

ID=25287846

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87902224T ATE109659T1 (de) 1986-03-21 1987-03-12 Arzneimittelzusammensetzungen.

Country Status (16)

Country Link
EP (1) EP0302065B1 (de)
JP (1) JPH01500589A (de)
KR (1) KR900001074B1 (de)
CN (1) CN87103560A (de)
AT (1) ATE109659T1 (de)
AU (1) AU608756B2 (de)
CA (1) CA1281645C (de)
DE (1) DE3750369T2 (de)
FI (1) FI95538C (de)
HK (1) HK88696A (de)
HU (1) HU207452B (de)
IE (1) IE65667B1 (de)
PT (1) PT84537A (de)
RU (1) RU1814559C (de)
WO (1) WO1987005505A1 (de)
ZA (1) ZA872018B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77573C (fi) * 1987-05-08 1989-04-10 Orion Yhtymae Oy Ny konsistens.
FR2634376B1 (fr) * 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
NZ230764A (en) * 1988-09-27 1991-01-29 Takeda Chemical Industries Ltd Enteric films comprising hydroxypropylmethylcellulose phthalate, polyethylene glycol and shellac; preparation thereof
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
US5439967A (en) * 1991-09-17 1995-08-08 Micro Vesicular Systems, Inc. Propylene glycol stearate vesicles
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
WO1998009645A1 (fr) * 1996-09-04 1998-03-12 Dott Research Laboratory Compositions medicamenteuses contenant des peptides, destinees a l'administration orale
CN1324234A (zh) 1998-09-25 2001-11-28 格利科克斯有限公司 果糖胺氧化酶,拮抗剂和抑制剂
CA2343357A1 (en) 1998-09-25 2000-04-06 Glycox Corporation Limited Fructosamine oxidase assay: methods and materials
IL126447A (en) * 1998-10-04 2004-09-27 Vascular Biogenics Ltd An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
WO2000022909A2 (en) * 1998-10-19 2000-04-27 Biotech Australia Pty. Limited Systems for oral delivery
US6884792B2 (en) 1999-01-08 2005-04-26 Marvin B. Bacaner Bretylium compositions and kits and their use in preventing and treating cardiovascular conditions
MXPA01007024A (es) 1999-01-08 2002-03-27 B Bacaner Marvin Composiciones y equipos novedosos de bretilio y su uso en la prevencion y el tratamiento de condiciones cardiovasculares.
CN1141974C (zh) * 2000-06-07 2004-03-17 张昊 结肠定位释放的口服生物制剂
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
JP4592041B2 (ja) * 2000-11-24 2010-12-01 株式会社Ｎｒｌファーマ 生活の質を改善する新規食品の製造法および用途
US8658202B2 (en) 2001-04-25 2014-02-25 Western University Of Health Sciences Coated drug delivery formulations
JP2003001090A (ja) * 2001-06-22 2003-01-07 Pauretsuku:Kk 流動層装置
JP5595626B2 (ja) * 2001-06-22 2014-09-24 株式会社パウレック コーティング装置
ES2386782T3 (es) 2002-03-08 2012-08-30 Philera New Zealand Limited Prevención y/o tratamiento de la enfermedad cardiovascular y/o la insuficiencia cardíaca asociada
US20060100278A1 (en) 2002-08-20 2006-05-11 Cooper Garth J S Dosage forms and related therapies
EP1778618B1 (de) 2004-07-19 2013-12-25 PhilERA New Zealand Limited Synthese von triethylenetetraminen
PL2079445T3 (pl) 2007-02-20 2016-04-29 Allergan Pharmaceuticals Int Ltd Stabilne kompozycje enzymów trawiennych
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
KR101968457B1 (ko) 2010-10-01 2019-04-11 앨러간 파마슈티컬스 인터내셔널 리미티드 장용 코팅된 저 강도 췌장 리파제 제제
RU2016119726A (ru) 2011-08-08 2018-11-02 Апталис Фарма Лтд. Способ проведения теста на растворение твердых композиций, содержащих пищеварительные ферменты
RU2519099C1 (ru) * 2012-11-08 2014-06-10 Федеральное государственное бюджетное учреждение науки Ордена Трудового Красного Знамени Институт нефтехимического синтеза им. А.В. Топчиева Российской академии наук (ИНХС РАН) Фармацевтическая композиция
US10184121B2 (en) 2013-06-28 2019-01-22 Allergan Pharmaceuticals International Limited Methods for removing viral contaminants from pancreatic extracts
ES2784227T3 (es) 2013-08-09 2020-09-23 Allergan Pharmaceuticals Int Ltd Composición de enzimas digestivos adecuada para la administración entérica
JP7233852B2 (ja) * 2018-04-17 2023-03-07 キョーリンリメディオ株式会社 変色が抑制された固形製剤
WO2020026570A1 (ja) * 2018-07-31 2020-02-06 株式会社親広産業 グルコース消費促進剤および解糖系促進剤
JP6612004B1 (ja) * 2018-07-31 2019-11-27 株式会社親広産業 グルコース消費促進剤および解糖系促進剤
WO2020026471A1 (ja) * 2018-07-31 2020-02-06 株式会社親広産業 グルコース消費促進剤および解糖系促進剤
JP6823212B1 (ja) 2020-01-31 2021-01-27 株式会社中田製作所 スクイズ装置
WO2023017537A1 (en) 2021-08-12 2023-02-16 Celagenex Research (India) Pvt. Ltd. Oral algal oil based gastro-intestinal tract permeable peptide composition
CN114313354B (zh) * 2021-12-29 2022-11-08 江南大学 一种基于红外加热的液体微胶囊固化装置及方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1416304A (fr) * 1961-10-10 1965-11-05 Smith Kline French Lab Perfectionnements apportés aux tablettes et comprimés renfermant une importante quantité d'ingrédient actif libéré pendant un laps de temps prolongé, et aux procédés pour leur préparation
GB1155036A (en) * 1966-07-08 1969-06-11 Ethan Allan Brown Injectionable Substance
YU36434B (en) * 1969-05-14 1984-02-29 Sanol Arznei Schwarz Gmbh Process for obtaining gelation capsules filled with the active substance resistant to gastric juice and dissolvable in the small intestine
US3922339A (en) * 1974-06-20 1975-11-25 Kv Pharm Co Sustained release medicant
US4356167A (en) * 1978-01-27 1982-10-26 Sandoz, Inc. Liposome drug delivery systems
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
US4447412A (en) * 1983-02-01 1984-05-08 Bilton Gerald L Enzyme-containing digestive aid compostions
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
JPS6058915A (ja) * 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms

Also Published As

Publication number Publication date
DE3750369D1 (de) 1994-09-15
JPH01500589A (ja) 1989-03-01
AU608756B2 (en) 1991-04-18
PT84537A (en) 1987-04-01
HU207452B (en) 1993-04-28
JPH0576928B2 (de) 1993-10-25
DE3750369T2 (de) 1995-05-24
WO1987005505A1 (en) 1987-09-24
CA1281645C (en) 1991-03-19
EP0302065A1 (de) 1989-02-08
AU7207387A (en) 1987-10-09
KR900001074B1 (ko) 1990-02-26
RU1814559C (ru) 1993-05-07
FI95538B (fi) 1995-11-15
CN87103560A (zh) 1988-05-18
FI884291A (fi) 1988-09-19
IE65667B1 (en) 1995-11-15
HUT48821A (en) 1989-07-28
KR870008587A (ko) 1987-10-19
FI95538C (fi) 1996-02-26
FI884291A0 (fi) 1988-09-19
EP0302065A4 (en) 1990-09-12
ZA872018B (en) 1988-02-24
IE870696L (en) 1987-09-21
EP0302065B1 (de) 1994-08-10
HK88696A (en) 1996-05-31

Similar Documents

Publication Publication Date Title
ATE109659T1 (de) Arzneimittelzusammensetzungen.
IT1246188B (it) Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
IT8519873A0 (it) Procedimento di solubilizzazione di principi attivi e composizioni farmaceutiche cosi' ottenute.
CA2330500A1 (fr) Compositions pharmaceutiques gelifiables
HUP0004396A2 (hu) A lipoprotein-oxidáció gátlására szolgáló, hatóanyagként hidroxilezett koleszterincsökkentő szert tartalmazó gyógyszerkészítmények
FI971776A (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
CA2246289A1 (fr) Nouvelles associations de principes actifs contenant du clopidogrel et un antithrombotique
NL194821B (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
CA2013755A1 (en) Medicinal emulsions
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
IL77467A (en) Drug-containing aerosol formulations comprising chlorofluorocarbon propellent
FR2502951B1 (fr) Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
ES541521A0 (es) Un procedimiento para la preparacion de piridazinaminas.
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
ES8403024A1 (es) Un procedimiento para la fabricacion de un preparado farmaceutico para uso externo, a base de un compuesto no esteroi- dico.
PT951473E (pt) Novos derivados da ciclosporina sua preparacao e composicoes farmaceuticas que os contem
IT8521603A0 (it) Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi.
EP0135171A3 (de) Pharmazeutische Zusammensetzung zur Anwendung von Interferon
NO158417C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive urinstoffer og tiourinstoffer.
IT8619288A0 (it) Formulazioni farmaceutiche iniettabili di principi attivi adattivita' anestetica generale.
EP0210703A3 (de) Acylphosphorotriamide verwendbar als lipid-modifizierendes Mittel
EP0335446A3 (de) Mittel zur Behandlung von Neoplasmen
FR2715849B1 (fr) Forme d'administration solide à délitescence rapide d'un principe actif.
KR900012613A (ko) 경구 투여용 의약조성물
ES2057542T3 (es) Agentes terapeuticos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee